JB Chemicals & Pharmaceuticals profit decreased 24.65% in (Q4) FY 2019-20

JB Chemicals & Pharmaceuticals Limited NSE Symbol:JBCHEPHARM, BSE Security Code:506943 has declared its 4th(fourth) quarter audited Consolidated financial report from the month of January, 2020 to the month of March, 2020; for the fiscal year 2019-20.

Revenue Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
446.74 445.01 434.57 1825.40 1684.64
Calculated Revenue of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
1.73 0.39%(Revenue Increase) 12.17 2.80%(Revenue Increase) 140.76 8.36%(Revenue Increase)

Revenue: JB Chemicals & Pharmaceuticals Limited's financial report shows that the company's revenue increased by 0.39% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for revenue increase of Rs.1.73 crores, as the company posted revenue of Rs.446.74 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported revenue of Rs.445.01 crores.
The result also shows that the company's revenue increased by 2.80% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for revenue increase of Rs.12.17 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted revenue of Rs.434.57 crores
The company also reported that its revenue increased by 8.36% in 12 months end(April, 2019 - March, 2020) for revenue increase of Rs.140.76 crores, since the company reported revenue of Rs.1825.40 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted revenue of Rs.1684.64 crores.

Gross Margin(%) Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
62.73 63.34 64.69 64.01 61.35
Calculated Gross Margin(%) of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
0.62 0.97%(GM Decrease) 1.97 3.04%(GM Decrease) 2.65 4.33%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 0.97% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for 0.62% GM decrease, as the company reported 62.73% GM; in compare to previous quarter(October, 2019 - December, 2019) when the company reported 63.34% GM.
The result also indicates, the company's GM decreased by 3.04% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for 1.97% GM decrease; in compare to corresponding quarter(January, 2019 - March, 2019) when the company reported 64.69% GM.
The company also reported that its GM increased by 4.33% in 12 months end(April, 2019 - March, 2020) for 2.65% GM increase, since the company reported 64.01% GM; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company reported 61.35% GM.

EBITDA Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
84.91 105.98 81.19 418.24 347.28
Calculated EBITDA of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
21.07 19.88%(EBITDA Decrease) 3.72 4.58%(EBITDA Increase) 70.96 20.43%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 19.88% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EBITDA decrease of Rs.21.07 crores, as the company posted EBITDA of Rs.84.91 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EBITDA of Rs.105.98 crores.
The result also shows that the company's EBITDA increased by 4.58% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EBITDA increase of Rs.3.72 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EBITDA of Rs.81.19 crores
The company also reported that its EBITDA increased by 20.43% in 12 months end(April, 2019 - March, 2020) for EBITDA increase of Rs.70.96 crores, since the company reported EBITDA of Rs.418.24 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EBITDA of Rs.347.28 crores.

Profit and Loss Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
50.07(Profit ) 66.45(Profit ) 46.79(Profit ) 272.39(Profit ) 193.97(Profit )
Calculated Profit and Loss of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
16.38 24.65%(Profit Decrease) 3.28 7.01%(Profit Increase) 78.42 40.43%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 24.65% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for profit decrease of Rs.16.38 crores, as the company posted profit of Rs.50.07 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported profit of Rs.66.45 crores.
The result also shows that the company's profit increased by 7.01% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for profit increase of Rs.3.28 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted profit of Rs.46.79 crores
The company also reported that its profit increased by 40.43% in 12 months end(April, 2019 - March, 2020) for profit increase of Rs.78.42 crores, since the company reported profit of Rs.272.39 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted profit of Rs.193.97 crores.

EPS Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
6.30 8.26 5.68 34.20 23.54
Calculated EPS of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
1.96 23.73%(EPS Decrease) 0.62 10.92%(EPS Increase) 10.66 45.28%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 23.73% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EPS decrease of Rs.1.96, as the company posted EPS of Rs.6.30; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EPS of Rs.8.26.
The result also shows that the company's EPS increased by 10.92% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EPS increase of Rs.0.62; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EPS of Rs.5.68
The company also reported that its EPS increased by 45.28% in 12 months end(April, 2019 - March, 2020) for EPS increase of Rs.10.66, since the company reported EPS of Rs.34.20; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EPS of Rs.23.54.

Assets Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Details Non-current Assets Current Assets
Current Quarter(March, 2020) Previous Year End(March, 2019) Current Quarter(March, 2020) Previous Year End(March, 2019)
Reported 740.83 740.80 1072.73 1051.15
  Change Change % Change Change %
Calculated 0.03 0.00%(Assets Increase) 21.58 2.05%(Assets Increase)

Assets:The company reported its non-current assets increased by 0.00% in current year end(March, 2020) for non-current assets increase of Rs.0.03 crore, since the company reported net non-current assets of Rs.740.83 crores; in compare to previous year end(March, 2019) when the company reported net non-current assets of Rs.740.80 crores.
The balance sheet of the company also shows that, its current assets increased by 2.05% in current year end(March, 2020) for current assets increase of Rs.21.58 crores, as the company reported net current assets of Rs.1072.73 crores; against previous year end(March, 2019) when the company reported net current assets of Rs.1051.15 crores.

Liabilities Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20
Details Non-current Liabilities Current Liabilities
Current Quarter(March, 2020) Previous Year End(March, 2019) Current Quarter(March, 2020) Previous Year End(March, 2019)
Reported 62.72 64.84 312.85 244.18
  Change Change % Change Change %
Calculated 2.12 3.27%(Liabilities Decrease) 68.67 28.12%(Liabilities Increase)

Liabilities:The company reported its non-current liabilities decreased by 3.27% in current year end(March, 2020) for non-current liabilities decrease of Rs.2.12 crores, since the company reported net non-current liabilities of Rs.62.72 crores; in compare to previous year end(March, 2019) when the company reported net non-current liabilities of Rs.64.84 crores.
The balance sheet of the company also shows that, its current liabilities increased by 28.12% in current year end(March, 2020) for current liabilities increase of Rs.68.67 crores, as the company reported net current liabilities of Rs.312.85 crores; against previous year end(March, 2019) when the company reported net current liabilities of Rs.244.18 crores.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Tags

Add new comment

Comment Editor

  • No HTML tags allowed.